Cyanogen bromide cleavage of the heavy (alpha) chain of protein 315 (an immunoglobulin A mouse myeloma protein with anti-dinitrophenyl activity) yielded five fragments of which one (CN2), with 156 residues, contained the chain's entire variable region. Determination of the amino-acid sequence of CN2 showed that: (1) the variable region has appreciable homology (about 33% identities) with the variable region of the light chain from the same molecule; and (2) the constantregion sequence immediately following the probable transition from variable to constant domains is the same in the protein-315 a as in human -yl and p chains (-ValSer-Ser-). The sequence of the cyanogen bromide octapeptide (CN5) from the carboxy terminus of the protein-315 heavy chain closely resembles the corresponding segments ofhuman a and ju chains.
Multiple lines of evidence show that the ligand-binding specificities of antibody molecules are determined by about 107 residues at the amino terminus of light chains and about 115 at the amino terminus of heavy chains (called VL and VH regions, respectively) (1-3). The complete amino-acid sequences for VL and VH of the same molecule have been established for two myeloma proteins (4-6), but their ligandbinding specificities are not known.
The purpose of this paper is to report the amino-acid sequence of the variable region of the heavy chain (H315) from protein 315 . This sequence and that previously reported for the light chain from the same molecule (7) provide an essentially complete primary structure for the VH and VL regions of protein 315. The results are of particular interest because this protein, an IgA myeloma protein produced by mouse plasmacytoma MOPC-315, is known to have ligand-binding sites that resemble in many ways those of antibodies against Dnp and Tnp raised by conventional immunization procedures (8) . For instance, protein 315 binds Dnp and Tnp ligands with high affinity, distinguishes sharply among ligands of similar structure (e.g., between 2, and 2,6-Dnp groups), and ex- (9) . The fragments obtained from cyanogen bromide degradation of the heavy chain were subjected to sequence analysis in the Beckman sequenator and by the dansyl-Edman procedure (10, 11) . Several of the fragments were degraded further with trypsin, chymotrypsin, and thermolysin into smaller peptides, which were purified by ion exchange chromatography on Dowex resins (12) , gel filtration, paper chromatography, and high-voltage electrophoresis. The amino-acid sequences of these peptides were determined with the aid of dansyl-Edman degradation and by digestion with carboxypeptidases A and B. Analysis of heavy chains from intact molecules that had been labeled with a specific affinity-labeling reagent ([14C]bromoacetylDnp-L-lysine) aided in identification of the fragment with the variable region (13) .
Cyanogen bromide cleavage of the fully reduced, aminoethylated heavy chain yielded five fragments that were purified largely by gel filtration on Sephadex (G-50 and G-100) in 5 M guanidine-HCl (Fig. 1 ). This report focuses on the 2nd and 5th fragments, CN2 and CN5, which correspond, respectively, to a large amino-terminal (variable) segment and a small carboxy-terminal (constant) segment of the chain. The other fragments, all derived from within the constant region, will be described elsewhere: here we note only that CN1 has approximately 228 residues, CN3 is a mixture of peptides, including one with carbohydrate, and CN4 is an octapeptide.
CN2 contains the entire VH region and the adjoining portion of the constant region, including the latter's first Cys peptide. It has 156 amino-acid residues and lacks carbohydrate. End-group analysis by the cyanate (R. A. Bradshaw, unpublished results) and methylisothiocyanate (10) procedures showed that the amino-terminal residue in both this fragment and in the intact heavy chain is aspartic acid. When the whole chain and CN2 were analyzed with the Beckman automatic sequenator, it was possible to identify the first nine residues of the chain and the first 49 of the frag-0.7r ment: both sequences were in complete agreement. Finally, when the affinity-labeled heavy chain (with [14C]bromoacetylDnp-L-lysine) was cleaved with cyanogen bromide and the fragments were separated as in Fig. 1 , only CN2 contained the 14C label; the label is known to attach to a lysine residue that, by homology with other VH sequences, was previously localized in the VH region (13) .
CN2 was reacted with maleic anhydride and then digested with trypsin (14) . The resulting arginine peptides, purified by ion exchange chromatography and gel filtration, accounted for the entire fragment. These peptides were subjected to sequence analysis and then aligned with the aid of other peptides derived from thermolytic and chymotryptic cleavages of CN2. The sequence from positions 1 to 156 is compared in Fig. 2 with the heavy chain of mouse protein 173 (an IgG myeloma protein produced by plasmacystoma MOPC-173) and with human heavy chains of various classes and VH subgroups (4-6, 15, 16) . The sequence from positions 38 to 67 in H315 corresponds to the affinity-labeled [14C]bromoacetylDnp-rlysine peptide previously reported by Haimovich et al.; lysine 52 is the specifically labeled residue (13) .
VH of protein 315 resembles other VH sequences: it contains the usual half-cystines and 20 of 22 residues found in nearly all VH sequences so far determined (Fig. 2) ; the two differences are conservative replacements (Thr for Ser at position 25;
Leu for Val at position 114). The switch from variable to constant regions has been established at position 115-116 for human yyl chains (4, 5) , and it may occur at the corresponding point in A heavy chains (17) . H315, a mouse a chain, also has the Val-Ser-Ser sequence that appears to mark the beginning of the constant region. If the switch from variable to constant region really occurs at this point, it is striking that the constant regions of such diverse heavy chains as human Syl, human MA, and mouse a all begin with the same sequence. This sequence could be conserved because of constraints imposed by the putative joining mechanism that is thought to unite V and C genes (18) (19) (20) .
The heavy chains of protein 315 and of protein 173 (15) are the only mouse heavy chains whose sequences have been extensively determined so far. Each has an unblocked aminoterminal (Glu or Asp), which is characteristic of human VH sequences of the VHIII subgroup (21) (22) (23) , and it has been suggested that this subgroup may be the predominant one in some nonprimate species (24) . However, the sequences of VH173 and VH315 differ markedly; the two are only 40% homologous and they differ by at least two sequence gaps (Fig.  2) . VH315 and VH173 are thus likely to represent different subgroups in the mouse and, therefore, different germ-line genes. Moreover, both VH315 and VH173 differ significantly in sequence from the human VHIII regions, and VH315 has as much overall homology with a representative member of the human VHII subgroup as with one from the VHIII subgroup.
Hence, not all unblocked heavy chains in the mouse correspond to the human VHIII subgroup. It is possible that diversity of VH sequences in the mouse may be as pronounced as the diversity in the mouse Vk family and in the human Vk, VX, VH families (25) (26) (27) (28) rather than being restricted as in mouse V> (29) .
In view of protein 315's ligand-binding activity, comparison of its VH and VL segments is of particular interest (Fig. 3) . When these regions are aligned according to the method of Fitch (30) One of the other cyanogen bromide fragments, CN5, was identified as the carboxy terminus of the heavy chain. It is the only fragment lacking homoserine: its carboxy-terminal residue is tyrosine, which is the same as that of intact H315. The sequence of this fragment is shown in Fig. 4 .
IgA has been detected so far only in mammals and in birds, while the phylogenetically antecedent amphibia have IgGlike and IgM-like proteins, and the lowest vertebrates (sharks) seem to have only IgM-like molecules (32, 33) . It has therefore been suggested that by duplication the gene for ju gave rise to genes for -y and then, relatively recently, for a (a, x2 ) Mouse a Met-Ser-Glx-Gly-Asx-Gly-Ile-Cys-Tyr Human a
Met-Ala-Glu-Val-Asp-Gly-Thr-Cys-Tyr Human u Met-Ser-Asx-Thr-Ala-Gly-Thr-Cys-Tyr Human Y1 Gln-Lys-Ser-Leu-Ser-Leu-Ser-Pro- Gly  FIG. 4 . Comparison of the carboxy-terminal nonapeptides of the heavy chains of protein 315 (a), human a, human ,u, and human yi (5, (34) (35) (36) . (34) . This proposal is in accord with the striking similarity between the carboxy-terminal sequences of human a, mouse a, and human A chains (Fig. 4) ; five of nine residues are identical. At the beginning of the constant region, however, the protein-315 a chain is hardly more homologous with human ,A than with human -y chains (Fig. 1) and, overall, a and -y are alike in that both are shorter by about one constant-region domain (about 110 residues) than ,u chains. Hence contemporary a and Sy might have arisen from a common precursor (derived from ,u), with conservation of the carboxy-terminal sequence in a for a specific biologic function. Additional sequence data on the constant region of H315 may help clarify the evolution of immunoglobulin chains.
